Item:Q21990: Difference between revisions
Created claim: instance of (P2): type of chemical entity (Q2546) |
Added link to [en]: Calcifediol |
||||||||||||||
(15 intermediate revisions by the same user not shown) | |||||||||||||||
Property / subclass of | |||||||||||||||
Property / subclass of: D3 vitamins / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / subclass of | |||||||||||||||
Property / subclass of: secosteroid / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / subclass of | |||||||||||||||
Property / subclass of: 9,10-secocholestane steroid / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / part of | |||||||||||||||
Property / part of: calcidiol binding / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / part of: calcidiol binding / qualifier | |||||||||||||||
Property / part of | |||||||||||||||
Property / part of: calcidiol 1-monooxygenase activity / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / part of | |||||||||||||||
Property / part of: vitamin D3 25-hydroxylase activity / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / part of | |||||||||||||||
Property / part of: 25-hydroxycholecalciferol-23-hydroxylase activity / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / has use | |||||||||||||||
Property / has use: medication / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / chemical structure | |||||||||||||||
Property / chemical structure: Calcidiol.png / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / chemical formula | |||||||||||||||
C₂₇H₄₄O₂ | |||||||||||||||
Property / chemical formula: C₂₇H₄₄O₂ / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / medical condition treated | |||||||||||||||
Property / medical condition treated: metabolic bone disease / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / medical condition treated | |||||||||||||||
Property / medical condition treated: vitamin D deficiency / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / medical condition treated | |||||||||||||||
Property / medical condition treated: secondary hyperparathyroidism of renal origin / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / medical condition treated: secondary hyperparathyroidism of renal origin / qualifier | |||||||||||||||
start time: 16 June 2016
| |||||||||||||||
Property / medical condition treated: secondary hyperparathyroidism of renal origin / qualifier | |||||||||||||||
Property / subject has role | |||||||||||||||
Property / subject has role: primary metabolite / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / Commons category | |||||||||||||||
Calcifediol | |||||||||||||||
Property / Commons category: Calcifediol / rank | |||||||||||||||
Normal rank | |||||||||||||||
links / en / name | links / en / name | ||||||||||||||